Deutsche Märkte geschlossen

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Other OTC - Other OTC Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
1,4950+0,2850 (+23,55%)
Börsenschluss: 03:29PM EDT

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Sektor(en)Healthcare
BrancheMedical Distribution
Vollzeitmitarbeiter48.164

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Qiuhua YangExecutive ChairmanN/AN/A1972
Mr. Bo ShenPresident, CFO, Head of the Accounting Department & Executive Director781,13kN/A1973
Mr. Yongzhong LiVP & Executive Director835,02kN/A1970
Mr. Ming DongExecutive DirectorN/AN/A1976
Mr. Tao ZhongVP, Board Secretary & Joint Company SecretaryN/AN/A1972
Mr. Dongming LiVice PresidentN/AN/A1969
Ms. Shuai ShaoVice PresidentN/AN/A1988
Dr. Shunjiang YuChief Medical OfficerN/AN/AN/A
Ms. Pui Kiu WongJoint Company SecretaryN/AN/AN/A
Ying KeDirector & General Manager of R&D Management CenterN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Corporate Governance

Shanghai Pharmaceuticals Holding Co., Ltds ISS Governance QualityScore, Stand 1. Mai 2024, lautet 8. Die grundlegenden Scores sind Audit: 7, Vorstand: 10, Shareholderrechte: 9, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.